Navigation Links
New System for Managing Sleep Disorders Aims to Improve Sleep Through Brain Chemistry
Date:5/12/2009

OSCEOLA, Wis., May 12 /PRNewswire/ -- NeuroScience, Inc. has launched NeuroSLP, a medical protocol that tests for potential imbalances in the hormones and neurotransmitters that regulate sleep. This protocol enhances a clinician's ability to make more informed decisions regarding patient care.

The NeuroSLP protocol is a major advance in the way healthcare practitioners approach sleep difficulties. The system combines cutting edge sleep biochemistry information with laboratory testing to help healthcare practitioners pinpoint potential imbalances, and develop more targeted therapeutic regimens for individual patients.

The protocol includes an enhanced non-invasive lab test that measures the key neurotransmitters and hormones in sleep biochemistry. The concentration of melatonin, classically considered the "sleep hormone," is only one of twelve biomarkers in the profile. Other sleep-influencing hormones and neurotransmitters measured include cortisol, y-amino butyric acid (GABA), and serotonin.

Coupled with an array of sleep-promoting interventions with differing modes of action, clinicians can use the protocol to tailor therapies to patients' individual biochemical profiles, potentially increasing positive outcomes and reducing unwanted side-effects. Eileen Wright, MD, of Great Smokies Medical Center in Asheville, North Carolina, stated, "Therapies guided by this testing have changed the lives of many individuals in my practice."

NeuroSLP is offered exclusively through clinicians and the test profile is submittable to insurance. Additional information regarding NeuroSLP can be found at www.neurorelief.com/neuroslp.

About NeuroScience, Inc.:

NeuroScience, Inc., established in 1998, is a research-based medical solutions company committed to improving health through the nervous system by providing novel laboratory assessments in the fields of neurology, endocrinology, and immunology. NeuroScience, Inc.'s, laboratory services through Pharmasan Labs, Inc. have been utilized to assess multiple clinical complaints. NeuroScience, Inc.'s database consists of over 300,000 individual results.


'/>"/>
SOURCE NeuroScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Compact cancer-therapy particle-delivery system patented
2. OrthoSynetics Selects Landslides Sales P3 System as its Corporate Sales System
3. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
4. Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation
5. Actuaries: Addressing Health Spending Growth is Path to Sustainable Health Care System
6. Scientists discover how smallpox may derail human immune system
7. TRIA Laser Hair Removal System Debuts on The Doctors
8. SEEBURGER Offers First B2B Integration between SAP & ePedigree Systems
9. Over 3,000 Skin Cancer Patients Treated with the TOPEX System.............
10. Ontario Systems Announces Record-Breaking First Quarter Fueled by Increase in New Client Agreements
11. Organizations Have Federal Government Tax Incentives to Purchase Remstar Automated Systems for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... Sanovas, Inc., a life science asset holding company ... wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed Intubation ... http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed annually ...
(Date:12/5/2016)... WOONSOCKET, R.I. , Dec. 5, 2016 /PRNewswire/ ... CVS ) Research Institute and the U.S. ... the Assistant Secretary for Preparedness and Response (ASPR), ... showed that automated pharmacy notifications encourage patients ... a forecasted natural disaster. The study also affirms ...
Breaking Medicine Technology: